.png){kind=icon}
.png){kind=icon}
Return
Real-world effectiveness of chemotherapy regimens after immunotherapy in patients with advanced melanoma in Spain: Results from the GEM1801 study
.png){kind=icon}
OA
AI
M
E
A
J
P
DOI：10.1002/cncr.70497.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Chemotherapy schemes have historically shown low efficacy in patients with metastatic melanoma and have been replaced by immunotherapy and targeted therapy. This work aimed to study whether chemotherapy remains an option after progression to immunotherapy in specific contexts.
Keywords:
chemotherapy
immune checkpoint inhibitors
metastatic melanoma
real-world
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
5.1
Papers:
2.0W
Citations:
6.2W
Organization
Cited Papers